Stock Market Live December 30, 2025: S&P 500 (SPY) Still Sliding into New Year

As we wrap up 2025, the major indices are flat again.

The S&P 500 is down about five points. The SPDR S&P 500 ETF (SPY) is down a few cents. The Dow is down by about 13, as the NASDAQ sinks by 44 points.

Metals are recovering this morning

In fact, after a brief pullback, gold, silver, and copper prices are soaring again. Gold is up about $58 today and could push even higher with growing geopolitical tension, economic uncertainty, expectations of further interest rate cuts, a weak dollar, and strong interest from central banks.

Silver prices are up about $5 to $76.04. And copper – on pace for its best year since 2009 – is regaining momentum thanks to unstoppable AI demand, and supply fears. Analysts say the rally in copper could continue well into the new year, too.

As noted by The Wall Street Journal, “Goldman Sachs raised its copper price forecast for the first half of next year to an average of $10,710 a ton from $10,415 previously, citing constrained mine-supply growth and structural demand from grid and power infrastructure. It also said physical traders suggest copper shipments into the U.S. could accelerate more than expected in early 2026. Copper prices are also supported by growing expectations that the Federal Reserve will lower interest rates further this year.”

Plus, moving forward, the amount of copper used in data centers globally could grow sixfold by 2050 from about half a million tonnes today. All of which puts even more stress on copper supply and demand issues.

Rocket Lab Soaring at the Open 

Shares of Rocket Lab (NASDAQ: RKLB | RKLB Price Prediction) are pushing higher just days after Needham raised their price target to $90 from $53 with a buy rating. Plus, the U.S. Space Development Agency awarded RKLB a prime contract to design and manufacture 18 satellites for the Tracking Layer Tranche 3 program under the Proliferated Warfighter Space Architecture.

Shares of Elanco Health (NYSE: ELAN) also continue to push higher on insider buying.

Since bottoming out in April at around $8 a share, ELAN is now up to $22.72 and could rally even higher.  Most recently, CEO Jeffrey Simmons paid $478,500 to buy 22,000 shares on December 11 at an average price of $21.75 a share. The company, which was spun off from Eli Lilly in 2018, has experienced explosive growth thanks to key product launches, including a chewable parasite preventative for dogs, as well as an anti-itch medication.

Contact [email protected] for any questions or corrections.